Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study

Rob W. van der Pluijm; Mallika Imwong; Nguyễn Hoàng Châu; Nhu Thi Hoa; Thuy-Nhien Nguyen; Ngo Viet Thanh; Podjanee Jittamala; Borimas Hanboonkunupakarn; Kitipumi Chutasmit; Chalermpon Saelow; Ratchadaporn Runjarern; Weerayuth Kaewmok; Rupam Tripura; Thomas J. Peto; Yok Sovann; Seila Suon; Sokunthea Sreng; Sivanna Mao; Savuth Oun; Sovannary Yen; Chanaki Amaratunga; Dysoley Lek; Rekol Huy; Mehul Dhorda; Kesinee Chotivanich; Elizabeth A. Ashley; Mavuto Mukaka; Naomi Waithira; Phaik Yeong Cheah; Richard J. Maude; Roberto Amato; Richard D. Pearson; Sónia Gonçalves; Christopher G. Jacob; William L. Hamilton; Rick M. Fairhurst; Joel Tärning; Markus Winterberg; Dominic Kwiatkowski; Sasithon Pukrittayakamee; Tran Tinh Hien; Nicholas Day; Olivo Miotto; Nicholas J. White; Arjen M. Dondorp (2019). Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study. The Lancet Infectious Diseases, 19(9), 952-961. https://doi.org/10.1016/s1473-3099(19)30391-3